Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 262

1.

MCR-8 mediated colistin resistance in a carbapenem-resistant Klebsiella pneumoniae isolated from a repatriated patient from Morocco.

Bonnin RA, Bernabeu S, Jaureguy F, Naas T, Dortet L.

Int J Antimicrob Agents. 2020 Feb 13:105920. doi: 10.1016/j.ijantimicag.2020.105920. [Epub ahead of print] No abstract available.

PMID:
32062001
2.

Evaluation of the Revogene® Carba C Assay for detection and differentiation of carbapenemase-producing Gram negative bacteria.

Girlich D, Laguide M, Dortet L, Naas T.

J Clin Microbiol. 2020 Jan 29. pii: JCM.01927-19. doi: 10.1128/JCM.01927-19. [Epub ahead of print]

3.

Stepwise evolution and convergent recombination underlie the global dissemination of carbapenemase-producing Escherichia coli.

Patiño-Navarrete R, Rosinski-Chupin I, Cabanel N, Gauthier L, Takissian J, Madec JY, Hamze M, Bonnin RA, Naas T, Glaser P.

Genome Med. 2020 Jan 20;12(1):10. doi: 10.1186/s13073-019-0699-6.

4.

First occurrence of the OXA-198 carbapenemase in Enterobacterales.

Bonnin RA, Jousset AB, Gauthier L, Emeraud C, Girlich D, Sauvadet A, Cotellon G, Jové T, Dortet L, Naas T.

Antimicrob Agents Chemother. 2020 Jan 13. pii: AAC.01471-19. doi: 10.1128/AAC.01471-19. [Epub ahead of print]

PMID:
31932369
5.

Biochemical and Structural Characterization of OXA-405, an OXA-48 Variant with Extended-Spectrum β-Lactamase Activity.

Oueslati S, Retailleau P, Marchini L, Dortet L, Bonnin RA, Iorga BI, Naas T.

Microorganisms. 2019 Dec 21;8(1). pii: E24. doi: 10.3390/microorganisms8010024.

6.

Different phenotypic expression of KPC β-lactamase variants and challenges in their detection.

Oueslati S, Tlili L, Exilie C, Bernabeu S, Iorga B, Bonnin RA, Dortet L, Naas T.

J Antimicrob Chemother. 2020 Mar 1;75(3):769-771. doi: 10.1093/jac/dkz508. No abstract available.

PMID:
31848599
7.

Phylogeny, Resistome, and Virulome of Escherichia coli Causing Biliary Tract Infections.

Rodríguez-Villodres Á, Bonnin RA, Ortiz de la Rosa JM, Álvarez-Marín R, Naas T, Aznar J, Pachón J, Lepe JA, Smani Y.

J Clin Med. 2019 Dec 2;8(12). pii: E2118. doi: 10.3390/jcm8122118.

8.

LMB-1 producing Citrobacter freundii from Argentina, a novel player in the field of MBLs.

Dabos L, Rodriguez CH, Nastro M, Dortet L, Bonnin RA, Famiglietti A, Iorga BI, Vay C, Naas T.

Int J Antimicrob Agents. 2020 Feb;55(2):105857. doi: 10.1016/j.ijantimicag.2019.11.014. Epub 2019 Nov 27.

PMID:
31785341
9.

Evaluation of the BD MAX Check-Points CPO Assay for the Detection of Carbapenemase Producers Directly from Rectal Swabs.

Girlich D, Oueslati S, Bernabeu S, Langlois I, Begasse C, Arangia N, Creton E, Cotellon G, Sauvadet A, Dortet L, Fortineau N, Naas T.

J Mol Diagn. 2020 Feb;22(2):294-300. doi: 10.1016/j.jmoldx.2019.10.004. Epub 2019 Nov 18.

10.

Improvement of the Immunochromatographic NG-Test Carba 5 Assay for the Detection of IMP Variants Previously Undetected.

Volland H, Girlich D, Laguide M, Gonzalez C, Paris V, Laroche M, Oueslati S, Dortet L, Simon S, Naas T.

Antimicrob Agents Chemother. 2019 Dec 20;64(1). pii: e01940-19. doi: 10.1128/AAC.01940-19. Print 2019 Dec 20.

PMID:
31685459
11.

Successful use of culture and enrichment for the detection of OXA-181-producing Escherichia coli from rectal swab samples falsely categorized as negative by Xpert® Carba-R.

Girlich D, Ouzani S, Langlois I, Begasse C, Arangia N, Fortineau N, Naas T, Dortet L.

Diagn Microbiol Infect Dis. 2020 Jan;96(1):114909. doi: 10.1016/j.diagmicrobio.2019.114909. Epub 2019 Oct 25.

PMID:
31677960
12.

A 2.5-years within-patient evolution of a Pseudomonas aeruginosa with in vivo acquisition of ceftolozane-tazobactam and ceftazidime-avibactam resistance upon treatment.

Boulant T, Jousset AB, Bonnin RA, Barrail-Tran A, Borgel A, Oueslati S, Naas T, Dortet L.

Antimicrob Agents Chemother. 2019 Oct 21. pii: AAC.01637-19. doi: 10.1128/AAC.01637-19. [Epub ahead of print]

PMID:
31636072
13.

Prospective evaluation of the Amplidiag® CarbaR+VRE assay for direct screening of carbapenemase producing gram-negative bacilli from rectal swabs.

Nadji S, Gaillot O, Hallaert C, Messaadi S, Loukili N, Naas T, Lemaître N.

Diagn Microbiol Infect Dis. 2019 Dec;95(4):114890. doi: 10.1016/j.diagmicrobio.2019.114890. Epub 2019 Aug 24.

PMID:
31630910
14.

Extended-spectrum resistance to β-lactams/β-lactamase inhibitors (ESRI) evolved from low-level resistant Escherichia coli.

Rodríguez-Villodres Á, Gil-Marqués ML, Álvarez-Marín R, Bonnin RA, Pachón-Ibáñez ME, Aguilar-Guisado M, Naas T, Aznar J, Pachón J, Lepe JA, Smani Y.

J Antimicrob Chemother. 2020 Jan 1;75(1):77-85. doi: 10.1093/jac/dkz393.

PMID:
31613964
15.

Optimization of the MALDIxin test for the rapid identification of colistin resistance in Klebsiella pneumoniae using MALDI-TOF MS.

Dortet L, Broda A, Bernabeu S, Glupczynski Y, Bogaerts P, Bonnin R, Naas T, Filloux A, Larrouy-Maumus G.

J Antimicrob Chemother. 2020 Jan 1;75(1):110-116. doi: 10.1093/jac/dkz405.

16.

Herpes Simplex Virus 1 Replication, Ocular Disease, and Reactivations from Latency Are Restricted Unilaterally after Inoculation of Virus into the Lip.

Poccardi N, Rousseau A, Haigh O, Takissian J, Naas T, Deback C, Trouillaud L, Issa M, Roubille S, Juillard F, Efstathiou S, Lomonte P, Labetoulle M.

J Virol. 2019 Nov 26;93(24). pii: e01586-19. doi: 10.1128/JVI.01586-19. Print 2019 Dec 15.

PMID:
31554680
17.

Evaluation of the Immunochromatographic NG-Test Carba 5 for Rapid Identification of Carbapenemase in Nonfermenters.

Potron A, Fournier D, Emeraud C, Triponney P, Plésiat P, Naas T, Dortet L.

Antimicrob Agents Chemother. 2019 Aug 23;63(9). pii: e00968-19. doi: 10.1128/AAC.00968-19. Print 2019 Sep.

PMID:
31285233
18.

Escherichia coli ST410 among humans and the environment in Southeast Asia.

Nadimpalli ML, de Lauzanne A, Phe T, Borand L, Jacobs J, Fabre L, Naas T, Le Hello S, Stegger M.

Int J Antimicrob Agents. 2019 Aug;54(2):228-232. doi: 10.1016/j.ijantimicag.2019.05.024. Epub 2019 Jun 7.

PMID:
31176748
19.

CHROMagar™ ESBL/mSuperCARBA bi-plate medium for detection of ESBL- and carbapenemase-producing Enterobacteriaceae from spiked stools.

Girlich D, Grosperrin V, Naas T, Dortet L.

Diagn Microbiol Infect Dis. 2019 Oct;95(2):107-112. doi: 10.1016/j.diagmicrobio.2019.05.002. Epub 2019 May 8.

PMID:
31171396
20.

Unravelling ceftazidime/avibactam resistance of KPC-28, a KPC-2 variant lacking carbapenemase activity.

Oueslati S, Iorga BI, Tlili L, Exilie C, Zavala A, Dortet L, Jousset AB, Bernabeu S, Bonnin RA, Naas T.

J Antimicrob Chemother. 2019 Aug 1;74(8):2239-2246. doi: 10.1093/jac/dkz209.

PMID:
31127297
21.

SME-4-producing Serratia marcescens from Argentina belonging to clade 2 of the S. marcescens phylogeny.

Dabos L, Patiño-Navarrete R, Nastro M, Famiglietti A, Glaser P, Rodriguez CH, Naas T.

J Antimicrob Chemother. 2019 Jul 1;74(7):1836-1841. doi: 10.1093/jac/dkz115.

PMID:
30993333
22.

Aztreonam plus Clavulanate, Tazobactam, or Avibactam for Treatment of Infections Caused by Metallo-β-Lactamase-Producing Gram-Negative Bacteria.

Emeraud C, Escaut L, Boucly A, Fortineau N, Bonnin RA, Naas T, Dortet L.

Antimicrob Agents Chemother. 2019 Apr 25;63(5). pii: e00010-19. doi: 10.1128/AAC.00010-19. Print 2019 May.

23.

Development and Multicentric Validation of a Lateral Flow Immunoassay for Rapid Detection of MCR-1-Producing Enterobacteriaceae.

Volland H, Dortet L, Bernabeu S, Boutal H, Haenni M, Madec JY, Robin F, Beyrouthy R, Naas T, Simon S.

J Clin Microbiol. 2019 Apr 26;57(5). pii: e01454-18. doi: 10.1128/JCM.01454-18. Print 2019 May.

24.

NG-Test Carba 5 for Rapid Detection of Carbapenemase-Producing Enterobacterales from Positive Blood Cultures.

Takissian J, Bonnin RA, Naas T, Dortet L.

Antimicrob Agents Chemother. 2019 Apr 25;63(5). pii: e00011-19. doi: 10.1128/AAC.00011-19. Print 2019 May.

25.

Genetic, Biochemical, and Structural Characterization of CMY-136 β-Lactamase, a Peculiar CMY-2 Variant.

Zavala A, Retailleau P, Elisée E, Iorga BI, Naas T.

ACS Infect Dis. 2019 Apr 12;5(4):528-538. doi: 10.1021/acsinfecdis.8b00240. Epub 2019 Mar 7.

PMID:
30788955
26.

False-Positive Carbapenem-Hydrolyzing Confirmatory Tests Due to ACT-28, a Chromosomally Encoded AmpC with Weak Carbapenemase Activity from Enterobacter kobei.

Jousset AB, Oueslati S, Bernabeu S, Takissian J, Creton E, Vogel A, Sauvadet A, Cotellon G, Gauthier L, Bonnin RA, Dortet L, Naas T.

Antimicrob Agents Chemother. 2019 Apr 25;63(5). pii: e02388-18. doi: 10.1128/AAC.02388-18. Print 2019 May.

27.

The challenges of designing a benchmark strategy for bioinformatics pipelines in the identification of antimicrobial resistance determinants using next generation sequencing technologies.

Angers-Loustau A, Petrillo M, Bengtsson-Palme J, Berendonk T, Blais B, Chan KG, Coque TM, Hammer P, Heß S, Kagkli DM, Krumbiegel C, Lanza VF, Madec JY, Naas T, O'Grady J, Paracchini V, Rossen JWA, Ruppé E, Vamathevan J, Venturi V, Van den Eede G.

Version 2. F1000Res. 2018 Apr 13 [revised 2018 Jan 1];7. pii: ISCB Comm J-459. doi: 10.12688/f1000research.14509.2. eCollection 2018. Review.

28.

Meat and Fish as Sources of Extended-Spectrum β-Lactamase-Producing Escherichia coli, Cambodia.

Nadimpalli M, Vuthy Y, de Lauzanne A, Fabre L, Criscuolo A, Gouali M, Huynh BT, Naas T, Phe T, Borand L, Jacobs J, Kerléguer A, Piola P, Guillemot D, Le Hello S, Delarocque-Astagneau E; BIRDY study group.

Emerg Infect Dis. 2019 Jan;25(1). doi: 10.3201/eid2501.180534.

29.

Transcriptional Landscape of a bla KPC-2 Plasmid and Response to Imipenem Exposure in Escherichia coli TOP10.

Jousset AB, Rosinski-Chupin I, Takissian J, Glaser P, Bonnin RA, Naas T.

Front Microbiol. 2018 Dec 3;9:2929. doi: 10.3389/fmicb.2018.02929. eCollection 2018.

30.

Evaluation of the Amplidiag CarbaR+MCR Kit for Accurate Detection of Carbapenemase-Producing and Colistin-Resistant Bacteria.

Girlich D, Bernabeu S, Grosperrin V, Langlois I, Begasse C, Arangia N, Creton E, Cotellon G, Sauvadet A, Dortet L, Naas T.

J Clin Microbiol. 2019 Feb 27;57(3). pii: e01800-18. doi: 10.1128/JCM.01800-18. Print 2019 Mar. No abstract available.

31.

Occurrence of carbapenemase-producing Enterobacteriaceae in Togo, West Africa.

Dossim S, Bonnin RA, Salou M, Tanga K, Godonou V, Dagnra AY, Prince David M, Naas T, Dortet L.

Int J Antimicrob Agents. 2019 Apr;53(4):530-532. doi: 10.1016/j.ijantimicag.2018.11.019. Epub 2018 Nov 24. No abstract available.

PMID:
30476571
32.

Carbapenemase-producing Acinetobacter spp. from environmental sources in a hospital in French Polynesia.

Bonnin RA, Levy M, Cuzon G, Dortet L, Naas T.

J Glob Antimicrob Resist. 2019 Mar;16:81-82. doi: 10.1016/j.jgar.2018.11.001. Epub 2018 Nov 13. No abstract available.

PMID:
30445212
33.

Rapid detection of colistin resistance in Acinetobacter baumannii using MALDI-TOF-based lipidomics on intact bacteria.

Dortet L, Potron A, Bonnin RA, Plesiat P, Naas T, Filloux A, Larrouy-Maumus G.

Sci Rep. 2018 Nov 15;8(1):16910. doi: 10.1038/s41598-018-35041-y.

34.

Higher Prevalence of PldA, a Pseudomonas aeruginosa Trans-Kingdom H2-Type VI Secretion System Effector, in Clinical Isolates Responsible for Acute Infections and in Multidrug Resistant Strains.

Boulant T, Boudehen YM, Filloux A, Plesiat P, Naas T, Dortet L.

Front Microbiol. 2018 Oct 29;9:2578. doi: 10.3389/fmicb.2018.02578. eCollection 2018.

35.

Development and validation of a multiplex polymerase chain reaction assay for detection of the five families of plasmid-encoded colistin resistance.

Jousset AB, Bernabeu S, Bonnin RA, Creton E, Cotellon G, Sauvadet A, Naas T, Dortet L.

Int J Antimicrob Agents. 2019 Mar;53(3):302-309. doi: 10.1016/j.ijantimicag.2018.10.022. Epub 2018 Nov 3.

PMID:
30395987
36.

Comparison of the Superpolymyxin and ChromID Colistin R Screening Media for the Detection of Colistin-Resistant Enterobacteriaceae from Spiked Rectal Swabs.

Girlich D, Naas T, Dortet L.

Antimicrob Agents Chemother. 2018 Dec 21;63(1). pii: e01618-18. doi: 10.1128/AAC.01618-18. Print 2019 Jan.

37.

Molecular characterization of plasmid-encoded Tripoli MBL 1 (TMB-1) in Enterobacteriaceae.

Gauthier L, Dortet L, Jousset AB, Mihaila L, Golse N, Naas T, Bonnin RA.

J Antimicrob Chemother. 2019 Jan 1;74(1):42-47. doi: 10.1093/jac/dky372.

PMID:
30252055
38.

Evaluation of the NG-Test CARBA 5 multiplex immunochromatographic assay for the detection of KPC, OXA-48-like, NDM, VIM and IMP carbapenemases.

Hopkins KL, Meunier D, Naas T, Volland H, Woodford N.

J Antimicrob Chemother. 2018 Dec 1;73(12):3523-3526. doi: 10.1093/jac/dky342. No abstract available.

PMID:
30189008
39.

Rapid detection and discrimination of chromosome- and MCR-plasmid-mediated resistance to polymyxins by MALDI-TOF MS in Escherichia coli: the MALDIxin test.

Dortet L, Bonnin RA, Pennisi I, Gauthier L, Jousset AB, Dabos L, Furniss RCD, Mavridou DAI, Bogaerts P, Glupczynski Y, Potron A, Plesiat P, Beyrouthy R, Robin F, Bonnet R, Naas T, Filloux A, Larrouy-Maumus G.

J Antimicrob Chemother. 2018 Dec 1;73(12):3359-3367. doi: 10.1093/jac/dky330.

PMID:
30184212
40.

Genetic and Biochemical Characterization of OXA-535, a Distantly Related OXA-48-Like β-Lactamase.

Dabos L, Jousset AB, Bonnin RA, Fortineau N, Zavala A, Retailleau P, Iorga BI, Naas T.

Antimicrob Agents Chemother. 2018 Sep 24;62(10). pii: e01198-18. doi: 10.1128/AAC.01198-18. Print 2018 Oct.

41.

Evaluation of the CRE and ESBL ELITe MGB® kits for the accurate detection of carbapenemase- or CTX-M-producing bacteria.

Girlich D, Bernabeu S, Fortineau N, Dortet L, Naas T.

Diagn Microbiol Infect Dis. 2018 Sep;92(1):1-7. doi: 10.1016/j.diagmicrobio.2018.02.001. Epub 2018 Feb 9.

PMID:
29983286
42.

MALDI-TOF for the rapid detection of carbapenemase-producing Enterobacteriaceae: comparison of the commercialized MBT STAR®-Carba IVD Kit with two in-house MALDI-TOF techniques and the RAPIDEC® CARBA NP.

Dortet L, Tandé D, de Briel D, Bernabeu S, Lasserre C, Gregorowicz G, Jousset AB, Naas T.

J Antimicrob Chemother. 2018 Sep 1;73(9):2352-2359. doi: 10.1093/jac/dky209.

PMID:
29897463
43.

Diversity of Carbapenemase-Producing Escherichia coli Isolates in France in 2012-2013.

Gauthier L, Dortet L, Cotellon G, Creton E, Cuzon G, Ponties V, Bonnin RA, Naas T.

Antimicrob Agents Chemother. 2018 Jul 27;62(8). pii: e00266-18. doi: 10.1128/AAC.00266-18. Print 2018 Aug.

44.

Proposing Kluyvera georgiana as the Origin of the Plasmid-Mediated Resistance Gene fosA4.

Rodriguez MM, Ghiglione B, Power P, Naas T, Gutkind G.

Antimicrob Agents Chemother. 2018 Jul 27;62(8). pii: e00710-18. doi: 10.1128/AAC.00710-18. Print 2018 Aug.

45.

Genetic and Biochemical Characterization of OXA-519, a Novel OXA-48-Like β-Lactamase.

Dabos L, Bogaerts P, Bonnin RA, Zavala A, Sacré P, Iorga BI, Huang DT, Glupczynski Y, Naas T.

Antimicrob Agents Chemother. 2018 Jul 27;62(8). pii: e00469-18. doi: 10.1128/AAC.00469-18. Print 2018 Aug.

46.

Whole-genome sequencing of NDM-1-producing ST85 Acinetobacter baumannii isolates from Tunisia.

Jaidane N, Naas T, Oueslati S, Bernabeu S, Boujaafar N, Bouallegue O, Bonnin RA.

Int J Antimicrob Agents. 2018 Dec;52(6):916-921. doi: 10.1016/j.ijantimicag.2018.05.017. Epub 2018 May 30.

PMID:
29857033
47.

Outbreak of IMI-1 carbapenemase-producing colistin-resistant Enterobacter cloacae on the French island of Mayotte (Indian Ocean).

Miltgen G, Bonnin RA, Avril C, Benoit-Cattin T, Martak D, Leclaire A, Traversier N, Roquebert B, Jaffar-Bandjee MC, Lugagne N, Filleul L, Subiros M, de Montera AM, Cholley P, Thouverez M, Dortet L, Bertrand X, Naas T, Hocquet D, Belmonte O.

Int J Antimicrob Agents. 2018 Sep;52(3):416-420. doi: 10.1016/j.ijantimicag.2018.05.015. Epub 2018 May 26.

PMID:
29807164
48.

Plasmid-mediated colistin resistance gene mcr-1 in a clinical Escherichia coli isolate in the Indian Ocean Commission.

Leroy AG, Naze F, Dortet L, Naas T, Jaubert J.

Med Mal Infect. 2018 Sep;48(6):426-428. doi: 10.1016/j.medmal.2018.04.388. Epub 2018 May 9. No abstract available.

PMID:
29753527
49.

A 4.5-Year Within-Patient Evolution of a Colistin-Resistant Klebsiella pneumoniae Carbapenemase-Producing K. pneumoniae Sequence Type 258.

Jousset AB, Bonnin RA, Rosinski-Chupin I, Girlich D, Cuzon G, Cabanel N, Frech H, Farfour E, Dortet L, Glaser P, Naas T.

Clin Infect Dis. 2018 Oct 15;67(9):1388-1394. doi: 10.1093/cid/ciy293.

PMID:
29688339
50.

Molecular Characterization of OXA-198 Carbapenemase-Producing Pseudomonas aeruginosa Clinical Isolates.

Bonnin RA, Bogaerts P, Girlich D, Huang TD, Dortet L, Glupczynski Y, Naas T.

Antimicrob Agents Chemother. 2018 May 25;62(6). pii: e02496-17. doi: 10.1128/AAC.02496-17. Print 2018 Jun.

Supplemental Content

Support Center